Treatment with cyclosporin A in a patient with Omenn’s syndrome
- A Meyer-Bahlburg1,
- J-P Haas3,
- R Haase1,
- U Eschrich1,
- A Wawer1,
- L Frank3,
- W Ch Marsch2,
- S Burdach1,
- G Horneff1
- 1Department of Pediatrics, Martin-Luther-University, School of Medicine, Halle/Saale, Germany
- 2Department of Dermatology and Venerology, Martin-Luther-University
- 3Children’s Hospital, Friedrich Alexander University Erlangen-Nürnberg, Germany
- Correspondence to:
Dr A Meyer-Bahlburg, Department of Pediatrics, Martin-Luther-University, School of Medicine, Ernst-Grube-Str. 40, D-06120 Halle, Germany;
almut.meyer-bahlburg{at}medizin.uni-halle.de
- Accepted 7 January 2002
Abstract
Unless treated with haematopoetic stem cell transplantation, Omenn’s syndrome, a rare variant of severe combined immunodeficiency, is associated with a fatal outcome. We describe a male infant showing all the typical features of Omenn’s syndrome, who was successfully treated with cyclosporin A to improve clinical condition prior to haematopoetic stem cell transplantation.
